121 related articles for article (PubMed ID: 916824)
1. Arylsulfonate esters as hypocholesteremic agents: III. Mechanism of action studies.
MacNintch JE; Harris RA; Grogan WM; Villemez CL; Quackenbush FW
Lipids; 1977 Oct; 12(10):819-27. PubMed ID: 916824
[TBL] [Abstract][Full Text] [Related]
2. The effect of arylsulfonate esters on cholesterol--aggravated atherosclerosis in White Carneau Pigeons.
Macnintch JE; St Clair RW; Lofland HB; Clarkson TB
Lipids; 1978 Oct; 13(10):644-8. PubMed ID: 723477
[TBL] [Abstract][Full Text] [Related]
3. Arylsulfonate esters of fatty alcohols as hypocholesterolemic agents. I: Oleyl and linoleyl p-toluenesulfonates.
Quackenbush FW; Rand PG; MacNintch JE
Lipids; 1977 Aug; 12(8):686-8. PubMed ID: 895419
[TBL] [Abstract][Full Text] [Related]
4. Arylsulfonate esters of fatty alcohols: IV. Effects on cholesterol catabolism.
Klauda HC; Bell FP; McLean Grogan W; Quackenbush W
Lipids; 1978 Oct; 13(10):627-35. PubMed ID: 214659
[No Abstract] [Full Text] [Related]
5. Phytosterol stearate esters elicit similar responses on plasma lipids and cholesterol absorption but different responses on fecal neutral sterol excretion and hepatic free cholesterol in male Syrian hamsters.
Ash MM; Hang J; Dussault PH; Carr TP
Nutr Res; 2011 Jul; 31(7):537-43. PubMed ID: 21840470
[TBL] [Abstract][Full Text] [Related]
6. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
[TBL] [Abstract][Full Text] [Related]
7. Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption.
Levrat-Verny MA; Behr S; Mustad V; Rémésy C; Demigné C
J Nutr; 2000 Feb; 130(2):243-8. PubMed ID: 10720177
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Kitayama K; Koga T; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
[TBL] [Abstract][Full Text] [Related]
10. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
Uchida T; Aoyama K; Watanabe T; Higuchi S
Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
[TBL] [Abstract][Full Text] [Related]
11. The influence of dietary saturated and unsaturated fat on hepatic cholesterol metabolism and the biliary excretion of chylomicron cholesterol in the rat.
Bravo E; Flora L; Cantafora A; De Luca V; Tripodi M; Avella M; Botham KM
Biochim Biophys Acta; 1998 Feb; 1390(2):134-48. PubMed ID: 9507091
[TBL] [Abstract][Full Text] [Related]
12. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.
van Heek M; Farley C; Compton DS; Hoos L; Davis HR
Br J Pharmacol; 2001 Sep; 134(2):409-17. PubMed ID: 11564660
[TBL] [Abstract][Full Text] [Related]
14. Linoleic acid amides: effect on cholesteremia and atherosclerosis.
Kritchevsky D; Tepper SA; Story JA
Lipids; 1977 Jan; 12(1):16-21. PubMed ID: 834120
[TBL] [Abstract][Full Text] [Related]
15. Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats.
Batta AK; Xu G; Bollineni JS; Shefer S; Salen G
Metabolism; 2005 Jan; 54(1):38-48. PubMed ID: 15562378
[TBL] [Abstract][Full Text] [Related]
16. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat.
Batta AK; Xu G; Honda A; Miyazaki T; Salen G
Metabolism; 2006 Mar; 55(3):292-9. PubMed ID: 16483871
[TBL] [Abstract][Full Text] [Related]
17. The cholesterol-lowering effect of guar gum is not the result of a simple diversion of bile acids toward fecal excretion.
Favier ML; Bost PE; Guittard C; Demigné C; Rémésy C
Lipids; 1997 Sep; 32(9):953-9. PubMed ID: 9307936
[TBL] [Abstract][Full Text] [Related]
18. Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters.
Wang X; Guan L; Zhao Y; Lei L; Liu Y; Ma KY; Wang L; Man SW; Wang J; Huang Y; Chen ZY
Atherosclerosis; 2015 Sep; 242(1):77-86. PubMed ID: 26184696
[TBL] [Abstract][Full Text] [Related]
19. Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats.
Visavadiya NP; Narasimhacharya AV
Evid Based Complement Alternat Med; 2009 Jun; 6(2):219-26. PubMed ID: 18955232
[TBL] [Abstract][Full Text] [Related]
20. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel.
Normén L; Dutta P; Lia A; Andersson H
Am J Clin Nutr; 2000 Apr; 71(4):908-13. PubMed ID: 10731496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
